67 related articles for article (PubMed ID: 27731537)
21. GCH1 mutations in dopa-responsive dystonia and Parkinson's disease.
Yoshino H; Nishioka K; Li Y; Oji Y; Oyama G; Hatano T; Machida Y; Shimo Y; Hayashida A; Ikeda A; Mogushi K; Shibagaki Y; Hosaka A; Iwanaga H; Fujitake J; Ohi T; Miyazaki D; Sekijima Y; Oki M; Kusaka H; Fujimoto KI; Ugawa Y; Funayama M; Hattori N
J Neurol; 2018 Aug; 265(8):1860-1870. PubMed ID: 29948246
[TBL] [Abstract][Full Text] [Related]
22. Variability of presynaptic nigrostriatal dopaminergic function and clinical heterogeneity in a dopa-responsive dystonia family with GCH-1 gene mutation.
Lin JJ; Lu CS; Tsai CH
J Neurol; 2018 Mar; 265(3):478-485. PubMed ID: 29290055
[TBL] [Abstract][Full Text] [Related]
23. [Dopa-responsive dystonia: clinical, genetic, and biochemical studies].
Furukawa Y
Rinsho Shinkeigaku; 2006 Jan; 46(1):19-34. PubMed ID: 16541791
[TBL] [Abstract][Full Text] [Related]
24. Dopamine transporter density measured by [123I]beta-CIT single-photon emission computed tomography is normal in dopa-responsive dystonia.
Jeon BS; Jeong JM; Park SS; Kim JM; Chang YS; Song HC; Kim KM; Yoon KY; Lee MC; Lee SB
Ann Neurol; 1998 Jun; 43(6):792-800. PubMed ID: 9629849
[TBL] [Abstract][Full Text] [Related]
25. Residual signs of dopa-responsive dystonia with GCH1 mutation following levodopa treatment are uncommon in Korean patients.
Ahn TB; Chung SJ; Koh SB; Park HY; Cho JW; Lee JH; Hong JY; Kwon DY; Shin C; Lee JY; Lee WW; Jeon B
Parkinsonism Relat Disord; 2019 Aug; 65():248-251. PubMed ID: 31213404
[TBL] [Abstract][Full Text] [Related]
26. Transcranial sonography in dopa-responsive dystonia.
Svetel M; Tomić A; Mijajlović M; Dobričić V; Novaković I; Pekmezović T; Brajković L; Kostić VS
Eur J Neurol; 2017 Jan; 24(1):161-166. PubMed ID: 27731537
[TBL] [Abstract][Full Text] [Related]
27. Molecular genetics of dopa-responsive dystonia.
Ichinose H; Suzuki T; Inagaki H; Ohye T; Nagatsu T
Biol Chem; 1999 Dec; 380(12):1355-64. PubMed ID: 10661862
[TBL] [Abstract][Full Text] [Related]
28. Dopa-responsive dystonia, DRD-plus and DRD look-alike: a pragmatic review.
Cherian A; Paramasivan NK; Divya KP
Acta Neurol Belg; 2021 Jun; 121(3):613-623. PubMed ID: 33453040
[TBL] [Abstract][Full Text] [Related]
29. Catecholamines and Parkinson's disease: tyrosine hydroxylase (TH) over tetrahydrobiopterin (BH4) and GTP cyclohydrolase I (GCH1) to cytokines, neuromelanin, and gene therapy: a historical overview.
Nagatsu T
J Neural Transm (Vienna); 2024 Jun; 131(6):617-630. PubMed ID: 37638996
[TBL] [Abstract][Full Text] [Related]
30. Dopa-responsive dystonia: a syndrome of selective nigrostriatal dopaminergic deficiency.
Jeon BS
J Korean Med Sci; 1997 Aug; 12(4):269-79. PubMed ID: 9288624
[TBL] [Abstract][Full Text] [Related]
31. Dystonia-plus syndromes.
Asmus F; Gasser T
Eur J Neurol; 2010 Jul; 17 Suppl 1():37-45. PubMed ID: 20590807
[TBL] [Abstract][Full Text] [Related]
32. GTP cyclohydrolase I gene, dystonia, juvenile parkinsonism, and Parkinson's disease.
Nagatsu T; Ichinose H
J Neural Transm Suppl; 1997; 49():203-9. PubMed ID: 9266429
[TBL] [Abstract][Full Text] [Related]
33. Clinical spectrum of dopa-responsive dystonia and related disorders.
Lee WW; Jeon BS
Curr Neurol Neurosci Rep; 2014 Jul; 14(7):461. PubMed ID: 24844652
[TBL] [Abstract][Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
